轩竹生物-B股价大涨5.03% 吡洛西利治疗乳腺癌临床III期研究数据于ESMO公布

港美通
Nov 03, 2025

11月3日14:53,轩竹生物-B(02575)股价大幅上涨5.03%。该股报66.800港元,最高报66.800港元,最低报62.000港元,成交量19.27万股,成交额1237.43万港元。消息面上,轩竹生物近日发布公告称,公司在2025年欧洲肿瘤内科学会(ESMO)上以壁报的形式展示了吡洛西利联合来曲唑或阿那曲唑在HR+/HER2-(激素受体阳性、人表皮生长因子受体2阴性)晚期乳腺癌一线治疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10